TEARLAB CORPORATION

Instrument Inactif

Communiqués TearLab Corporation

Actions

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

TEARLAB CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	09/07/20	AQ
TearLab: 1Q Earnings Snapshot	26/06/20	AQ
TEARLAB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	26/06/20	AQ
TEARLAB : Entry into a Material Definitive Agreement (form 8-K/A)	08/06/20	AQ
TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)	29/05/20	AQ
TEARLAB CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	13/05/20	AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	12/05/20	AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	11/05/20	AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	11/05/20	AQ
TearLab : Announces Acquisition By Accelmed Partners And Related $25 Million Investment	11/05/20	PR
TEARLAB CORP : Other Events, Financial Statements and Exhibits (form 8-K)	07/05/20	AQ
TearLab Corporation Confirms Merger Discussions	07/05/20	GL
TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test	22/04/20	GL
TEARLAB CORP : Change in Directors or Principal Officers, Other Events (form 8-K)	21/04/20	AQ
TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)	07/04/20	AQ
TEARLAB : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	06/03/20	AQ
TearLab: 4Q Earnings Snapshot	05/03/20	AQ
TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results	05/03/20	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez la Performance de vos Investissements grâce à notre Équipe d'Experts à vos Côtés

Sécuriser mes Investissements

fermer